Select Committee on Health Minutes of Evidence


Memorandum by Professor Iain Broom, Counterweight (OB 23)

INTRODUCTION

  1.  We would like to submit the following information on behalf of the Counterweight Project Team[1]The Counterweight project is a multi-centre obesity project being conducted in 80 general practices in the UK. The centres are Aberdeen, Bath, Birmingham, Glasgow, Hammersmith, Leeds and Luton.

  2.  All of the information detailed below is original data generated by the project. It is important to note that this work has been presented at academic conferences and journals. The Counterweight project has evidence to submit under the subject headings of "What can be done about it?", "Are institutional structures in place to deliver an improvement?" and "Recommendations for national and local strategy".

WHAT CAN BE DONE ABOUT IT:

Counterweight Programme Model

  3.  A national group of consultant physicians who specialise in obesity management recognised the need to tackle obesity in primary care. As a result, the idea for a national obesity pilot in primary care was developed. Roche Products Ltd. agreed to support the initiative, and the Counterweight Project Team* was formed in July 1999. The overall aim is to improve the management of obesity in primary care, thus reducing the disease burden of obesity in the population. The project has a number of objectives:

    —  To collect national anonymised obesity data from primary care registers

    —  To develop treatment models for obesity in primary care

    —  To facilitate the implementation of these treatment models into primary care

    —  To evaluate the impact of these models of care, and to inform future practice

  4.  Specialist obesity dieticians conduct audit, provide staff training, clinical support and facilitate the implementation of protocols in each practice. Patient screening and treatment guidelines have been developed to provide structure and guidance for practices in the management of obese patients. Clinicians are encouraged to see patients for six appointments of 10-20 minutes over a three-month period and at least quarterly thereafter. An integrated package of patient education materials have been developed to support the intervention programme. These leaflets cover a wide range of topics from healthy eating and low fat snacks to physical activity and behaviour change. The materials have a reading age of 12 years or less, and are designed to be used selectively and when appropriate.

  5.  There are two major lifestyle approaches: goal setting or a more structured prescribed eating plan based on 500-600 kcal energy deficit (Frost et al 1991; Leslie et al 2002). These approaches are designed to be used independently based on the needs and preferences of the patient. A structure for a three-month group programme for patients has been developed and is offered as a treatment option for practices. There is considerable evidence to support the use of such lifestyle approaches, both individual and group formats, in the management of obesity (SIGN 1996; RCGP 1998; NIH 1998). The usefulness of these materials and approaches will be evaluated by both clinicians and patients.

  6.  Evaluation will include re-audit of practice outcomes following two years of intervention to assess changes in clinician knowledge, attitude, perceived confidence and willingness to treat obesity, as well as changes in practice approaches to obesity management and weight screening rates. The primary end point for the patient intervention programme will be the percentage of patients achieving 5% and 10% weight loss. Secondary end points include changes in obesity-related co-morbidities including changes in blood pressure, lipids, diabetes control and medication usage. The Counterweight Programme will provide pivotal data on the feasibility and effectiveness of a structured approach to managing obese patients in primary care.

  7.  Seventy-three practices have been audited to asses current approaches to obesity management and the health and resource implications of obesity (see section "Are institutional structures in place to deliver an improvement?"). To date 48 practices have completed the training programme and 39 practices are currently providing a structured approach for managing obese patients. Over 900 obese patients have been recruited nationally into the intervention programme. The preliminary results from the intervention programme indicate that clinically beneficial weight loss can be achieved in high risk obese patients in primary care. We expect to continue recruiting patients till the end of 2004 and will await the final results before making any conclusions about the efficacy of the Counterweight approach. These results will be published in relevant medical journals.

ARE INSTITUTIONAL STRUCTURES IN PLACE TO DELIVER AN IMPROVEMENT:

  8.  An audit undertaken in 73 practices nationally as part of the Counterweight project has provided data on how general practitioners (GPs) and practice nurses (PNs) are currently managing obese patients. This includes self-reported practice and actual practice as determined by audit of medical records. Data presented here is based on the first 40 practices. Further analysis of the audit data has shown important health and resource implications of obesity; this evidence is not presented here however, as it is awaiting presentation at the European Congress on Obesity in Helsinki in May 2003.

  9.   Clinician self-reported approaches to managing obese patients: 141 GPs and 66 PNs from 40 Counterweight practices participated in structured interviews in which clinicians self-reported their approaches to obesity management. 83% of GPs and 97% of PNs reported that they would raise weight as an issue with obese patients (P<0.01). Few GPs (15%) reported spending up to 10 minutes in a consultation discussing weight-related issues, compared to PNs (76%; P<0.00001). Approaches commonly reported by GPs were a referral to a PN (78%), dietician (58%), exercise referral scheme (50%) and commercial weight loss agency (41%). Similarly PNs referred to a dietician (59% ; P=0.90) or exercise scheme (56%; P=0.44), but PNs referred more often to commercial agencies (68%; P<0.001). Three practices (7.5%) held specific obesity/dietetic clinics, all other practices saw patients opportunistically at existing clinics/appointments. Lifestyle management in primary care is based on brief opportunistic intervention undertaken mainly by PNs. There appears to be a reliance on external sources of weight management support (Abstract presented at Diabetes UK and published in Diabetic Medicine, Reckless et al 2003).

  10.   Clinician knowledge, attitudes and confidence in managing obese patients: We examined by questionnaire the knowledge, attitude, confidence and willingness of primary care staff to treat obesity. 180 General Practitioners (GPs) & 96 Practice Nurses (PNs) participate in the Counterweight Programme, a seven-centre, 40-practice obesity project. The questionnaire was returned by 64% of GPs (46% male) and 73% of PNs (all female). Knowledge scores were poor for GPs and PNs (36.1%: 38.7%; P=0.27). While both groups recognised medical consequences of obesity and central fat distribution, knowledge was poor for practical nutrition and physical activity recommendations. GPs and PNs had relatively higher scores for attitude (59.4/80: 64.3/80)(GPs<PNs; P<0.001), confidence (149/225; 147/225; P=0.77) and willingness to treat scores (8.0/10; 8.6/10)(GP<PN; P<0.05). Females had more positive attitudes irrespective of clinician type (P<0.05). Gender, clinician type or years in practice did not influence other scores. Limited basic nutrition and physical activity knowledge may limit GP and PN ability to effectively promote lifestyle change. PNs were more optimistic about lifestyle management. (Abstract presented at Diabetes UK and published in Diabetic Medicine, Reckless et al 2003).

  11.   Audit of obese patient records in primary care: Medical records were reviewed for 100 randomly selected obese patients (BMI> 30) from 40 UK practices (n=4,000) in seven-centre Counterweight programme. Data were collected on practice-based diet counselling, dietetic or obesity centre referrals, and anti-obesity medication. Recorded over 18 months were practice-based diet counselling (20%), dietetic (4%) and obesity centre (1%) referrals, and any anti-obesity medication (2%). Major obesity-related co-morbidities (diabetes, dyslipidaemia, hypertension, coronory heart disease) were independent multi-variate predictors of counselling (P<0.001) and dietetic referral (P<0.001) as was higher BMI (P<0.05 for counselling, P<0.001 dietic referral). Patients referred to obesity centres were younger (42.3: 49.6 yr; P<0.01) and more obese (BMI 39.8: 34.4;P<0.01) than those not referred. Patients prescribed anti-obesity medication were more likely to be female (P<0.01), younger (P=0.07) and more obese (P<0.01) but with similar co-morbidity prevalence (P=0.98) than those not prescribed. Practice-based counselling is the most common intervention. Obesity severity and co-morbidities predict practice-based diet counselling and dietetic referral. However co-morbidity prevalence did not influence referrals to obesity centres or the prescribing of anti-obesity medication. (Abstract presented at Diabetes UK and published in Diabetic Medicine, Laws et al 2003).

  12.  Practice Nurses (PNs) provide weight management screening and advice, an essential component of diabetes management. Little is known about level of screening and accessibility to necessary tools. Recording of weight/BMI was assessed by searching computerised medical records (n=182, 474) in 40 Counterweight practices. Availability of weighing scales and height measures were assessed along with source and accessibility of patient literature. Women were more likely than men to have a weight (69.2%; 57.0%; P<0.0001) or BMI (70.6%; 57.7%; P<0.0001) ever recorded. Equipment found in counsulting rooms was: weighing scales (96 per cent), height measures (89%), and accessible literature (36%). 65 leaflet types were found (mean 3.8 leaflets/practice, range zero-eight). Literature was from food or pharmaceutical industries (37%), local sources (26%) and Health Education Authority (18.5%), with small proportions from Health Education Board Scotland (6%), popular press (5%), Diabetes UK (1.5%), World Cancer Research Fund (1.5%), British Hypertension Society (1.5%) and unknown sources (3%). An improvement in recording of weight and BMI is a priority to meet targets for diabetes prevention and control. Patient literature was variable in source, accessibility and quality. (Abstract presented at Diabetes UK and published in Diabetic Medicine, Ross et al 2003).

RECOMMENDATION FOR NATIONAL AND LOCAL STRATEGY

  13.  Prioritisation of obesity by Primary Care Trusts: Programme outcomes need to be determined before strategic recommendations can be made and the usefulness of this model. An important element of the programme is that practices are not provided with additional funding for nurse time and implement the model within existing practice resources. Thirty-nine practices are currently recruiting patients into the programme; however nine practices out of the 48 who have completed the training programme have been unable to implement the Counterweight project. The main barriers to continued provision of a structured approach to obesity management have been competing priorities and lack of dedicated nurse time. Many practices however claim to be prioritising nurse and GP time to meet the national service frameworks for conditions such as diabetes and coronary heart disease. Ironically many of these competing disease areas can be directly improved by obesity management. The provision of dedicated funds may be required for obesity to be more effectively tackled in primary care as has happened in smoking cessation. It may be unrealistic to expect practices to manage obesity as part of existing funding for disease areas covered by national service frameworks. The Counterweight project team will be undertaking further qualitative research to examine barriers to practice involvement with obesity management. The aim will be to publish these results in relevant academic journals to use the findings to guide future strategies in primary care.

April 2003

REFERENCES

  Frost, G, Masters, K, King, C, Kelly, M, Hasan, U, Heavens, P, White, R and Stanford, J (1991): A new method of energy prescription to improve weight loss. Journal of Human Nutrition and Dietetics, 4, 369-374.

  Leslie, WS, Lean, MEJ, Baillie HM and Hankey, CR (2002): Weight management: a comparison of existing dietary approached in a work-site setting. Int J Obes, 26, 1469-1475.

  Scottish Intercollegiate Guidelines Network (1996): Obesity in Scotland: Integrating Prevention with Weight Management. Scottish Intercollegial Guidelines Network.

  The Royal College of Physicians of London (1998): Clinical Management of Overweight and Obese Patients, with particular reference to the use of drugs, RCGP, London.

  National Heart, Lung and Blood Institute (1998): The Practical Guide. Identification, Evaluation and Treatment of Overweight and Obesity in Adults. National Institute of Health.

  Reckless, JPD on behalf of the Counterweight Project Team. How does the primary care team intend to tackle the obesity epidemic in their high risk patients? Diabetic Medicine, 20, 103.

  Reckless, JPD on behalf of the Counterweight Project Team. Knowlege, attitudes and confidence of general practitioners and practice nurses in lifestyle management. Diabetic Medicine, 20, 77.

  Laws, RA on behalf of the Counterweight Project Team. How are general practitioners (GPs) and practice nurses (PNs) currently managing obese patients? Diabetic Medicine, 20, 103.

  Ross, HM on behalf of the Counterweight Project Team. Weight/BMI screening and availability of patient education literature in general practice. Diabetic Medicine, 20, 77.

APPENDIX 1

  Counterweight Project Team:

  a:  Weight Management Adviser (WMA),

  b:  Principal Investigator (PI),

  c:  Research Nurse,

  d:  Counterweight Project Co-ordinator,

  e:  Data and statistical analyists.

  1:  Aberdeen, 2: Bath, 3: Birmingham, 4: Glasgow, 5: Hammersmith, 6: Leeds, 7: Luton.

Name, Qualifications and Institutional affiliation of Authors:

  1a:  Ms Helen Gibbs, PG Dip Diet SRD, Clinical Research Unit, Grampian University Hospitals Trust.

  1b:  Professor J Broom, MBChB, MRCP (Glas), FRCPath, Consultant in Clinical Biochemistry & Metabolic Medicine, Research & Development, Grampian University Hospitals Trust.

  1c:  Mrs Jenny Brown, BA (Hons) CNS, Clinical Research Unit, Grampian University Hospitals Trust.

  2a:  Ms Rachel Laws, MSc (Nutrition & Dietetics), SRD, Nutritition & Dietetic Service, Royal United Hospital, Bath.

  2b:  Dr John Reckless, MD FRCP, Consultant Endocrinologist and Hon. Reader in Medicine & Biochemistry, University of Bath, Royal United Hospital, Bath.

  3a:  Ms Paula Noble, PGDipDiet, PG Dip (management studies), SRD, Birmingham Heartlands & Solihull NHS Trust.

  3b:  Dr Sudhesh Kumar, MD FRCP, Reader in Human Metabolism, Birmingham University, Heartlands & Solihull NHS Trust.

  4a:  Ms Louise McCombie, PGDipDiet, SRD, Department of Human Nutrition, Glasgow Royal Infirmary.

  4b:  Professor Mike Lean, MA, MD, FRCP, FRCPS, Department of Human Nutrition, Glasgow Royal Infirmary.

  5a:  Ms Felicity Lyons, PGDipDiet, SRD, Nutrition & Dietetic Research Group, Hammersmith Hospitals NHS Trust.

  5b:  Dr Gary Frost, PhD SRD, Head of Nutrition & Dietetic Service, SRD & Honorary Reader in Nutrition, Hammersmith Hospitals NHS Trust.

  6a:  Marney Quinn, BSc (Nutrition & Dietetics), SRD, Leeds General Infirmary, Leeds NHS Trust.

  6b:  Dr Julian H Barth, MD FRCP FRCPath, Leeds General Infirmary, Leeds NHS Trust.

  7a:  Ms Sarah Haynes, PGDipDiet, PGDipHealthSci, SRD, Centre for Obesity Research, Luton and Dunstable Hospital NHS Trust.

  7b:  Dr Nick Finer, FRCP, Consultant Endocrinologist, Centre for Obesity Research, Luton and Dunstable Hospital NHS Trust.

  7c:  Hazel Ross, PGDipDiet, SRD, Roche Products Ltd.

  7d:  Professor David Hole, MSc FFPHM, Public Health and Health Policy, Division of Community Based Sciences, University of Glasgow.

  7e:  Dr Ali Montazeri, MPH, PhD FFPHM, Public Health and Health Policy, Division of Community Based Sciences, University of Glasgow.





1   Not printed. Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2004
Prepared 27 May 2004